The Proteomics & Peptide Synthesis Core

provides research services in proteomics, protein analysis by mass spectrometry, and other techniques, as well as custom peptide synthesis. The Core offers the full range of services in qualitative and quantitative proteomics, including the preparation of (unprocessed) clinical research samples as well as biological samples.

Our Process

Consultation

To get started with the Proteomics and Peptide Synthesis Core, schedule a consultation. We’ll work with you to determine which service is right for your project, and help with experimental design to maximize quality of the results.

Sample Submission

When you’re ready to submit samples, fill out a request form and bring your samples to C570D/C568 MSRB II.

Data Analysis

When the analysis is complete, a full report is generated and delivered to you via email. We’re happy to set-up a follow-up meeting to discuss your results and perform further data analysis, as necessary.

Henriette Remmer, Ph.D.

Director, Proteomics & Peptide Synthesis Core

Dr. Henriette Remmer received her M.S. and Ph.D. in Biochemistry. Dr. Remmer’s expertise in peptide and protein chemistry, including protein mass spectrometry, is backed by years of research and core facility experience. Dr. Remmer regularly participates in research studies and has provided leadership to international research committees in proteomics, protein sequencing, and protein mass spectrometry, as well as peptide synthesis, with the Association for Biomolecular Resource Facilities (ABRF).
General Information

734-763-6285

Virtual Office Hours

News

  • BRCF Core Holiday Hours for November 2023

    In observance of the upcoming November holidays, many of our cores have adjusted their operations. If you have questions about hours or access, please use the core’s contact information listed below. Advanced Genomics Core Core services will be unavailable after …

     
  • AGC Onboards Xenium!

    The Advanced Genomics Core has acquired the 10x Genomics Xenium, an instrument that enables transcriptomic analysis at a subcellular level while maintaining spatial context. This technology comes with pre-validated biologically relevant targets for tissue panels, and up to 100 additional …

         

Events

No items found
Translate »